Leading Contract Research Organization in Mumbai

1. Strategies for Successful Multicentric Trials: Lessons from TECCRO’s Global Network and a Leading Contract Research Organization in Mumbai

2. Multicentric trials have many advantages, but at the same time, they are a complex undertaking that requires seamless coordination, strict protocol adherence, and localized expertise across different geographic regions and demographics. For every clinical research precision, compliance and subject engagement are crucial more so in the field of aesthetics- where multicentric trials pose both a great challenge and opportunity. As one of the best clinical research organizations in Mumbai, TECCRO’s global network is trusted by sponsors looking to scale their clinical research operations. TECCRO has a robust framework in place for conducting multicentric trials with consistency, quality, and global collaboration with the best workforce in all centres.

3. TECCRO’s CRO presence is pan-India and has strategic international partnerships, positioning it among the top clinical research organizations in Mumbai. Below, we highlight the tried-and-tested strategies that TECCRO employs to boost its multicentric aesthetic clinical trials and how their global coordination model is setting industry standards. • Why are multicentric trials important in clinical research? • Multicentric trials means research at geographically diverse research sites, and they offer many benefits in aesthetic medicine, dermatology, and cosmetic surgery where patient preferences, skin types, expectations, and treatment responses vary by region. These include • Greater patient recruitment potential • Improved data diversity with a larger sample size • Enhanced external validity sharing resources across centres

4. Quicker trial timelines through synchronized enrolment and data analysis • Greater reproducibility • Better control on study quality • This is one of the reasons that TECCRO is recognized mong the top 20 clinical research companies in India: their ability to ensure data inclusivity by aligning multicentric research with regulatory and scientific rigor. • The success of multi-centric or multi-site trials largely depends on harmonious site engagement and site research teams. TECCRO holds the expertise in detecting the bias and traps in multicentre clinical research and pays great attention to inclusion indication criteria, target identification, and how the trial is carried out. • TECCRO’s core strategies for Multicentric trial success • 1. Robust site selection and feasibility assessment • Stable site feasibility is the bedrock of any multicentric study. TECCRO uses a data-driven

5. site selection approach for investigator expertise, infrastructure availability, patient pool demographics, and regulatory compliance. TECCRO maintains a proprietary database for all its vetted sites specializing in supporting clinical trials. This wide and dependable network ensures a rapid startup without compromising on compliance, making TECCRO a part of top 50 contract research organizations in India. • 2. Standardized SOPs with local adaptation • TECCRO’s SOPs provide uniformity, but it also has a room for adapting to local realities. TECCRO uses unified SOP frameworks and formulates tailored execution plans based on city-specific needs, keeping the cultural and linguistic localization in mind during interactions. • Whether it is a TECCRO site in Mumbai, Hyderabad, or Chennai, the harmonized SOPs ensure that there is consistent trial conduct with localized materials. • 3. Centralized Ethics Oversight with IEC • A major roadblock in multicentric trials are delays because of multiple ethical submissions.

6. TECCRO has its own in-house ethics committee, which means simpler and accelerated protocol reviews, implementing unified ethical governance and maintaining a real-time communication with investigators. IEC gives TECCRO a competitive edge, making it a preferred partner for sponsors worldwide and also making it a recognized top clinical research institute in India. • 4. Technology-driven data collection and monitoring • TECCRO has invested in strong tech infrastructure and uses 21 CFR Part 11-compliant EDC systems along with real-time data verification tools for standardized, timely, and audit-ready research. For the multi-centric approach, remotion monitoring of dashboards and central imaging and visual assessment reviews are used. This commitment boosts their position among the top clinical research organizations in Mumbai. • 5. Engagement and Training • TECCRO improves the efficiency of clinical trials by conducting regular virtual and on-site

7. training programs, protocol walkthroughs and dry-run simulations and sharing best practices from other sites to ensure alignment. • TECCRO’s unique journal club encourages continuous learning to help elevate the knowledge of all stakeholders and hence the site performance overall, reaffirming TECCRO’s standing in the top 20 clinical research companies in India. • 6. Real-time project management • TECCRO is committed to providing the best services across all its sites and employs project managers who act as a single point of contact for all sites. They monitor milestones and deviations in real-time and coordinate logistics, supplies and sponsor communications. • Its agile and centralized project management style enables it to execute complex multi-centric trials on time and within budget. • Why TECCRO is the first choice of Globa; Sponsors for Multicentric Aesthetic Trails • Niche aesthetic expertise • Nationwide site network

8. Speed and ethics • Scalable operations • Trusted by top sponsors • India is fast emerging as the global hub for aesthetic clinical research. With its diverse skin types, cost-effective operations, and skilled investigators, it offers an ideal setting for multicentric trials. TECCRO is at the helm of this transformation by integrating global standards into the local insights. Focus on quality, ethics, and innovation makes TECCRO the best clinical research institute in mumbai. • Final thoughts • Multicentric trials are not just about the location; their success depends on coordination, culture, and consistency among the sites. TECCRO has perfected this art of multicentric clinical research with innovation and integrity, where every trial is a step towards global clinical excellence.

9. THANK YOU